Guobang Pharma Ltd - Asset Resilience Ratio

Latest as of June 2026: 9.44%

Guobang Pharma Ltd (605507) has an Asset Resilience Ratio of 9.44% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Guobang Pharma Ltd current assets vs equity to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

CN¥1.08 Billion

≈ $157.31 Million USD Cash + Short-term Investments

Total Assets

CN¥11.38 Billion

≈ $1.67 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2019–2025)

This chart shows how Guobang Pharma Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Guobang Pharma Ltd (605507) total assets.

Liquid Assets Composition Over Time

This chart breaks down Guobang Pharma Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read total liabilities of Guobang Pharma Ltd for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥1.08 Billion	9.44%
Total Liquid Assets	CN¥1.08 Billion	9.44%

Asset Resilience Insights

Limited Liquidity: Guobang Pharma Ltd maintains only 9.44% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Guobang Pharma Ltd Industry Peers by Asset Resilience Ratio

Compare Guobang Pharma Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Torrent Pharmaceuticals Limited NSE:TORNTPHARM	Drug Manufacturers - Specialty & Generic	2.79%
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Drug Manufacturers - Specialty & Generic	1.54%
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt F:RIG2	Drug Manufacturers - Specialty & Generic	0.20%
Beijing Tongrentang Co Ltd SHG:600085	Drug Manufacturers - Specialty & Generic	2.51%
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	Drug Manufacturers - Specialty & Generic	3.47%
Shan Dong Dong-E E-Jiao Co Ltd SHE:000423	Drug Manufacturers - Specialty & Generic	20.44%
Harbin Pharmaceutical Group Co Ltd SHG:600664	Drug Manufacturers - Specialty & Generic	0.97%
Kangmei Pharmaceutical Co Ltd SHG:600518	Drug Manufacturers - Specialty & Generic	0.00%

Annual Asset Resilience Ratio for Guobang Pharma Ltd (2019–2025)

The table below shows the annual Asset Resilience Ratio data for Guobang Pharma Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	11.32%	CN¥1.24 Billion ≈ $181.88 Million	CN¥10.98 Billion ≈ $1.61 Billion	+5.59pp
2024-12-31	5.73%	CN¥617.66 Million ≈ $90.38 Million	CN¥10.78 Billion ≈ $1.58 Billion	+1.23pp
2023-12-31	4.50%	CN¥465.99 Million ≈ $68.19 Million	CN¥10.36 Billion ≈ $1.52 Billion	-4.62pp
2022-12-31	9.12%	CN¥824.56 Million ≈ $120.66 Million	CN¥9.04 Billion ≈ $1.32 Billion	-7.63pp
2021-12-31	16.75%	CN¥1.26 Billion ≈ $184.12 Million	CN¥7.51 Billion ≈ $1.10 Billion	+16.75pp
2020-12-31	0.00%	CN¥34.78K ≈ $5.09K	CN¥5.51 Billion ≈ $806.08 Million	-3.15pp
2019-12-31	3.15%	CN¥149.87 Million ≈ $21.93 Million	CN¥4.76 Billion ≈ $696.45 Million	--

pp = percentage points

About Guobang Pharma Ltd

SHG:605507 China Drug Manufacturers - Specialty & Generic

Market Cap

$2.09 Billion

CN¥14.29 Billion CNY

Market Cap Rank

#6062 Global

#1167 in China

Share Price

CN¥18.26

Change (1 day)

+1.16%

52-Week Range

CN¥14.70 - CN¥29.25

All Time High

CN¥43.71